晚期卵巢癌初始诊疗中的关键问题  

Key issues concerning the diagnosis and primary treatment of advanced ovarian cancer

作　　者：胡沙 王泽华[1] Hu Sha;Wang Zehua(Department of Obstetrics and Gynecology,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China)

机构地区：[1]华中科技大学同济医学院附属协和医院妇产科,武汉430022

出　　处：《中国医师杂志》2025年第1期1-4,共4页Journal of Chinese Physician

摘　　要：大多数卵巢癌发现时即为晚期,肿瘤细胞减灭术联合术后化疗是其最重要的治疗方式。本文对可疑晚期卵巢癌患者的初始诊断、分期评估、肿瘤细胞减灭术的时机选择、手术途径及术后化疗中的关键问题进行综合阐述,对晚期卵巢癌的初始诊疗做出合理的选择,以期提高患者的生存期。Most ovarian cancer is found in the advanced stage,tumor cell reduction combined with postoperative chemotherapy is the most important treatment.In this paper,the key issues in the initial diagnosis,stage assessment,timing selection of tumor reduction surgery,surgical approach and postoperative chemotherapy of patients with suspected advanced ovarian cancer are comprehensively described,so as to make reasonable choices for the initial diagnosis and treatment of advanced ovarian cancer,in order to improve the survival time of patients.

关 键 词：卵巢肿瘤 细胞减灭术 化学疗法 辅助 

分 类 号：R737.31[医药卫生—肿瘤]